Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 144 results.
User Information
Export Records
  1. 1.   Distinct allosteric networks in CDK4 and CDK6 in the cell cycle and in drug resistance
  2. Zhang,Wengang; Bradburn, Devin; Heidebrink, Gretchen; Liu, Yonglan; Jang,Hyunbum; Nussinov,Ruth; Kõivomägi, Mardo
  3. Journal of Molecular Biology. 2025, Mar 31; 169121.
  1. 2.   The SRC family kinase inhibitor NXP900 demonstrates potent anti-tumor activity in squamous cell carcinomas
  2. Dash,Sweta; Hanson, Sabrina; King, Ben; Nyswaner, Katherine; Foss, Kelcie; Tesi,Noelle; Harvey, Mungo J B; Navarro-Marchal, Saúl A; Woods, Allison; Poradosu, Enrique; Unciti-Broceta, Asier; Carragher, Neil O; Brognard,John
  3. The Journal of Biological Chemistry. 2024, Jul 30; 107615.
  1. 3.   Regulation of RAF family kinases: new insights from recent structural and biochemical studies
  2. Spencer-Smith, Russell; Morrison,Deborah
  3. Biochemical Society Transactions. 2024, June 26; 52(3): 1061-1069.
  1. 4.   Slower CDK4 and faster CDK2 activation in the cell cycle
  2. Zhang,Wengang; Liu,Yonglan; Jang,Hyunbum; Nussinov,Ruth
  3. Structure (London, England : 1993). 2024, Apr 23;
  1. 5.   PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer
  2. Torres-Ayuso, Pedro; Katerji,Meghri; Mehlich, Dawid; Lookingbill, Sophia A; Sabbasani, Venkata R; Liou, Hope; Casillas, Andrea L; Chauhan, Shailender S; Serwa, Remigiusz; Rubin,Maxine; Marusiak, Anna A; Swenson, Rolf E; Warfel, Noel A; Brognard,John
  3. Cell Chemical Biology. 2023, Nov 16;
  1. 6.   RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation
  2. Smith,Russell; Terrell,Elizabeth; Insinna, Christine; Agamasu, Constance; Wagner, Morgan E; Ritt,Daniel; Stauffer,Jimmy; Stephen,Andy; Morrison,Deborah
  3. Molecular Cell. 2022, Nov 17; 82(22): 4262-4276.
  1. 7.   The mechanism of Raf activation through dimerization
  2. Zhang,Mingzhen; Maloney,Ryan; Jang,Hyunbum; Nussinov,Ruth
  3. Chemical Science. 2021, Dec 08; 12(47): 15609-15619.
  1. 8.   A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor
  2. Huang, Yongjian; Ognjenovic,Jana; Karandur, Deepti; Miller, Kate; Merk,Alan; Subramaniam, Sriram; Kuriyan, John
  3. eLife. 2021, Nov 30; 10
  1. 9.   Mechanism of activation and the rewired network: New drug design concepts
  2. Nussinov,Ruth; Zhang,Mingzhen; Maloney, Ryan; Tsai,Chung-Jung; Yavuz, Bengi Ruken; Tuncbag, Nurcan; Jang, Hyunbum
  3. Medicinal research reviews. 2021, Oct 25; 0198-6325:
  1. 10.   Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development
  2. Peerzada, Mudasir Nabi; Hamel,Ernest; Bai,Ruoli; Supuran, Claudiu T.; Azam, Amir
  3. Pharmacology & therapeutics. 2021, Sep; 225
  1. 11.   Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
  2. Wu, Jing; Yuan, Ying; Long-Priel,Debra; Fink,Dani; Peer, Cody J.; Sissung, Tristan M.; Su, Yu-Ting; Pang, Ying; Yu, Guangyang; Butler, Madison K.; Mendoza, Tito R.; Vera, Elizabeth; Ahmad, Salman; Bryla, Christine; Lindsley, Matthew; Grajkowska, Ewa; Mentges, Kelly; Boris, Lisa; Antony, Ramya; Garren, Nancy; Siegel, Christine; Lollo, Nicole; Cordova, Christine; Aboud, Orwa; Theeler, Brett J.; Burton, Eric M.; Penas-Prado, Marta; Leeper, Heather; Gonzales, Javier; Armstrong, Terri S.; Calvo, Katherine R.; Figg, William D.; Kuhns,Doug; Gallin, John; Gilbert, Mark R.
  3. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 2021, Jun 15; 27(12): 3298-3306.
  1. 12.   New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases
  2. Bensen, Ryan; Brognard,John
  3. International Journal of Molecular Sciences. 2021, Mar; 22(6):
  1. 13.   PIK3Cd expression by fibroblasts promotes triple-negative breast cancer progression
  2. Gagliano, Teresa; Shah, Kalpit; Gargani, Sofia; Lao, Liyan; Alsaleem, Mansour; Chen, Jianing; Ntafis, Vasileios; Huang, Penghan; Ditsiou, Angeliki; Vella, Viviana; Yadav, Kritika; Bienkowska, Kamila; Bresciani, Giulia; Kang, Kai; Li, Leping; Carter, Philip; Benstead-Hume, Graeme; O'Hanlon,Tim; Dean,Michael; Pearl, Frances Mg; Lee, Soo Chin; Rakha, Emad A; Green, Andrew R; Kontoyiannis, Dimitris L; Song, Erwei; Stebbing, Justin; Giamas, Georgios
  3. The Journal of clinical investigation. 2020, JUN 1; 130(6): 3188-3204.
  1. 14.   Ras assemblies and signaling at the membrane
  2. Nussinov,Ruth; Tsai,Chung-Jung; Jang,Hyunbum
  3. Current opinion in structural biology. 2020, JUN; 62: 140-148.
  1. 15.   Combing the Cancer Genome for Novel Kinase Drivers and New Therapeutic Targets
  2. Torres-Ayuso,Pedro; Brognard,John
  3. CANCERS. 2019, Dec; 11(12):
  1. 16.   Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases
  2. Kondo, Yasushi; Ognjenovic,Jana; Banerjee, Saikat; Karandur, Deepti; Merk,Alan; Kulhanek, Kayla; Wong, Kathryn; Roose, Jeroen P.; Subramaniam, Sriram; Kuriyan, John
  3. SCIENCE. 2019, OCT 4; 366(6461): 109-+.
  1. 17.   Orange is the new black: Kinases are the new master regulators of tumor suppression
  2. An,Elvira; Brognard,John
  3. IUBMB LIFE. 2019, JUN; 71(6): 738-748.
  1. 18.   Allosteric activation of RAF in the MAPK signaling pathway
  2. Tsai,Chung-Jung; Nussinov,Ruth
  3. CURRENT OPINION IN STRUCTURAL BIOLOGY. 2018, Dec; 53: 100-106.
  1. 19.   KIT Suppresses BRAF(V600E)-Mutant Melanoma by Attenuating Oncogenic RAS/MAPK Signaling
  2. Neiswender, James V.; Kortum, Robert L.; Bourque, Caitlin; Kasheta, Melissa; Zon, Leonard I.; Morrison, Deborah; Ceol, Craig J.
  3. Cancer Research. 2017, Nov 01; 77(21): 5820-5830.
  1. 20.   Crystal Structure of a Complex of the Intracellular Domain of Interferon lambda Receptor 1 (IFNLR1) and the FERM/SH2 Domains of Human JAK1
  2. Zhang, D.; Wlodawer, A.; Lubkowski, J.
  3. Journal of Molecular Biology. 2016, 2016-11-20; 428(23): 4651-4668.
  1. 21.   Farnesylated and methylated KRAS4b: high yield production of protein suitable for biophysical studies of prenylated protein-lipid interactions
  2. Gillette, W. K.; Esposito, D.; Abreu Blanco, M.; Alexander, P.; Bindu, L.; Bittner, C.; Chertov, O.; Frank, P. H.; Grose, C.; Jones, J. E.; Meng, Z.; Perkins, S.; Van, Q.; Ghirlando, R.; Fivash, M.; Nissley, D. V.; McCormick, F.; Holderfield, M.; Stephen, A. G.
  3. Scientific Reports. 2015 5: 15916.
  1. 22.   The importance of Raf dimerization in cell signaling
  2. Freeman, A. K.; Ritt, D. A.; Morrison, D. K.
  3. Small GTPases. 2013, Jul-Sep; 4(3): 180-5.
  1. 23.   Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
  2. Logue, J. S.; Morrison, D. K.
  3. Genes & Development. 2012, Apr; 26(7): 641-650.
  1. 24.   Identification of a Src Tyrosine Kinase/SIAH2 E3 Ubiquitin Ligase Pathway That Regulates C/EBP delta Expression and Contributes to Transformation of Breast Tumor Cells
  2. Sarkar, T. R.; Sharan, S.; Wang, J.; Pawar, S. A.; Cantwell, C. A.; Johnson, P. F.; Morrison, D. K.; Wang, J. M.; Sterneck, E.
  3. Molecular and Cellular Biology. 2012, Jan; 32(2): 320-332.
  1. 25.   A Computational Tool for Quantitative Analysis of Vascular Networks
  2. Zudaire, E.; Gambardella, L.; Kurcz, C.; Vermeren, S.
  3. Plos One. 2011, Nov; 6(11): 12.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel